A recent population-based cohort study conducted in Denmark found a significant association between low-dose aspirin use and increased rates of anemia among older adults. 

U.S. pharmaceutical companies are seeking to lessen their reliance on China-based companies for drug production, ingredients and research, The Wall Street Journal reported Nov. 1. 

All doses of Novo Nordisk's Wegovy and Ozempic are now available in the U.S following a two-year shortage, according to the FDA drug shortage list, which was updated Oct. 30. 

Fort Myers, Fla.-based Lee Health has become the first multisite health system in the U.S. to receive the American Society of Health-System Pharmacists' Certified Center of Excellence designation in Medication Use Safety and Pharmacy Practice. 

Weekly injections of semaglutide, the active ingredient in Ozempic and Wegovy, led to significant reductions in body weight and knee osteoarthritis-related pain, according to a phase 3 study by Novo Nordisk. 

The FDA granted accelerated approval to asciminib for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. 

A modified dosing regimen of donanemab led to a 41% reduction in the risk of amyloid-related imaging abnormalities with edema/effusion (ARIA-E) in early symptomatic Alzheimer's patients, according to a recent study. 

The American Pharmacists Association voiced concern over the rising number of pharmacy closures, saying they threaten access to pharmacists, particularly in rural and underserved communities, according to an Oct. 29 news release from the organization. 

Novant Health Enterprises, a division of Winston-Salem, N.C.-based Novant Health, has debuted a company aimed at enhancing retail, infusion and specialty pharmacy services across the Southeast. 

Becker's asked chief pharmacy officers from hospitals and health systems across the U.S. to share their most beneficial partnerships in 2024.

A recent study revealed a 17.5% increase in asthma-related hospitalizations in the three months following the announcement that GSK would discontinue the widely used asthma medication Flovent, and 24.1% in the following three to six months, ABC News reported Oct. 30. 

GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia. 

Vanderbilt Health Rx Solutions, a branch of Nashville, Tenn.-based Vanderbilt University Medical Center, has launched a consulting service aimed at enhancing patient care and optimizing drug launches. 

Here are nine new drug shortages to know, according to databases compiled by the FDA and the American Society of Health-System Pharmacists. 

The World Health Organization said global antibiotic use could drop by 22% annually if vaccines against 23 specific pathogens were widely developed, The Washington Post reported Oct. 26. 

Dallas pharmacy owner Ivor Jallah, 37, has been sentenced to 10 years in federal prison for a large-scale healthcare fraud scheme in which he billed insurers for medications never provided to patients. 

Thousands of CVS workers in Southern California have reached a tentative agreement on a new contract after a weekend strike, ABC News reported Oct. 24. 

The FDA's Pharmacy Compounding Advisory Committee is set to meet Dec. 4 to address regulatory questions on compounding practices, according to an Oct. 25 news release from the agency. 

With high-cost specialty drugs making up an ever-greater percentage of new launches, and prices for existing brand biologics on an ongoing upward trajectory, biosimilars – lower cost alternatives to these expensive medications – brought with them the promise of lower costs for everyone. Yet, despite their potential, uptake has been slow and this promise has failed to materialize. Here’s a look at the top five challenges facing the biosimilars market today.

The high cost of prescription drugs in the U.S. has emerged as a pressing issue for many voters this election cycle.